Department of Public Health, University of Helsinki, Helsinki, Finland.
Clin Epidemiol. 2011 Feb 15;3:51-9. doi: 10.2147/CLEP.S16114.
Biology is complex and the effects of many interventions may vary between population groups. Subgroup analysis can give estimates for specific populations, but trials are usually too small for such analyses.
To test whether the effect of vitamin E on pneumonia risk is uniform over subgroups defined by smoking and exercise.
The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study examined the effects of vitamin E (50 mg per day) and β-carotene (20 mg per day) on lung cancer in 29,133 male smokers aged 50-69 years using a 2 × 2 factorial design. The trial was conducted among the general community in Finland during 1985-1993; the intervention lasted for 6.0 years (median). In the present study, we tested the uniformity of vitamin E effect on the risk of hospital-treated pneumonia (898 cases) by adding a dummy variable to allow each subgroup its own vitamin E effect in a Cox model covering all participants.
Vitamin E effect was not uniform over eight subgroups defined by baseline smoking (5-19 vs ≥20 cigarettes per day), age of smoking initiation (≤20 vs ≥21 years), and exercise during leisure time (yes vs no). Vitamin E decreased pneumonia risk by 69% (95% CI: 43% to 83%) among participants who had the least exposure to smoking and exercised during leisure time. Vitamin E increased pneumonia risk by 79% (95% CI: 27% to 150%) among those who had the highest exposure to smoking and did not exercise.
Although the evidence of heterogeneity is strong, it is not evident to what extent the estimates of effect or the limits between the subgroups can be extrapolated to other populations.
Subgroup analysis of large trials should be encouraged, though caution is needed in the interpretation of findings. The role of vitamin E in susceptibility to pneumonia in physically active nonsmokers warrants further study.
ClinicalTrials.gov NCT00342992.
生物学是复杂的,许多干预措施的效果可能因人群群体而异。亚组分析可以为特定人群提供估计值,但试验通常太小,无法进行此类分析。
检验维生素 E 对肺炎风险的影响是否在吸烟和运动定义的亚组之间一致。
α-生育酚β-胡萝卜素癌症预防研究使用 2×2 析因设计,检查了维生素 E(每天 50 毫克)和β-胡萝卜素(每天 20 毫克)对 29133 名年龄在 50-69 岁的男性吸烟者肺癌的影响。该试验在芬兰的普通社区中进行,时间为 1985-1993 年;干预持续了 6.0 年(中位数)。在本研究中,我们通过添加一个虚拟变量来允许每个亚组在涵盖所有参与者的 Cox 模型中具有自己的维生素 E 效应,从而测试了维生素 E 对医院治疗肺炎(898 例)风险的影响是否一致。
维生素 E 效应在八个亚组中不一致,这些亚组根据基线吸烟情况(每天 5-19 支与≥20 支)、吸烟起始年龄(≤20 岁与≥21 岁)和闲暇时间运动情况(是与否)进行定义。在吸烟最少且闲暇时间运动的参与者中,维生素 E 降低肺炎风险 69%(95%CI:43%-83%)。在吸烟最多且不运动的参与者中,维生素 E 增加肺炎风险 79%(95%CI:27%-150%)。
尽管存在强烈的异质性证据,但尚不清楚效应估计值或亚组之间的界限在多大程度上可以外推到其他人群。
应鼓励对大型试验进行亚组分析,但在解释结果时需要谨慎。维生素 E 在身体活跃的不吸烟者对肺炎易感性中的作用值得进一步研究。
ClinicalTrials.gov NCT00342992。